Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02275208 · ClinicalTrials.gov registry record
A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure
A clinical trial of Obesity, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 120
- Enrollment target
- 7
- Study locations
NCT02275208: Completed study of Obesity, sponsored by Medtronic - MITG.
NCT02275208 is a study of Obesity that has completed, run by Medtronic - MITG. The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02275208, a study of Obesity, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure. Subjects who meet the eligibility criteria will be considered for study participation and will be followed through 12 months.
Conditions Studied
Interventions
- PROCEDURE SIPS the stomach, intestinal, pylorus, sparing procedure
Study Locations (7)
New York
- - Mount Kisco
- - New York
North Carolina
- - Cary
- - Durham
Colorado
- - Parker
Florida
- Florida Hospital Celebration Health - Celebration
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-12-11 |
| Est. Completion | 2017-01-18 |
What the finished NCT02275208 record still lists
NCT02275208 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which SIPS the stomach, intestinal, pylorus, sparing procedure is the first listed.
NCT02275208 lists 7 locations in 5 states (New York, North Carolina, Colorado).
Frequently Asked Questions
What is clinical trial NCT02275208 about?
NCT02275208 is a clinical study titled "A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure". This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure. Subjects who meet the eligibility criteria will be considered for study participation and will be followed through 12 months.
What is the current status of trial NCT02275208?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-12-11. Estimated completion is 2017-01-18.
What conditions does trial NCT02275208 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT02275208?
The interventions under investigation include: SIPS the stomach, intestinal, pylorus, sparing procedure (PROCEDURE).
Who is sponsoring clinical trial NCT02275208?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02275208 being conducted?
This trial has 7 study locations across Colorado, Florida, New York, North Carolina, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02275208's enrollment target sits among peer trials
120 434th of 1053 higher than 607 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI